SCHEMBL29567792

SCHEMBL29567792

Cc1ccccc1Oc1nc(NS(=O)(=O)c2cnn(C)c2)nc(-c2c(C)cccc2C)c1C1CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 12/20 0.39
▸ HTR7 P34969 12/20 0.39
▸ DRD2 P14416 5/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ THRB P10828 1/20 0.33
▸ HTR2A P28223 4/20 0.33
▸ PIK3CD O00329 1/20 0.32
▸ PIK3CB P42338 1/20 0.32
▸ MTOR P42345 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ PCK1 P35558 1/20 0.32
▸ SLC8A1 P32418 1/20 0.32
▸ CCNT1 O60563 2/20 0.31
▸ CCNB2 O95067 2/20 0.31
▸ CCNE2 O96020 2/20 0.31
▸ CDK1 P06493 2/20 0.31
▸ CCNB1 P14635 2/20 0.31
▸ CCNE1 P24864 2/20 0.31
▸ CDK2 P24941 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310759 1.00 HTR1A (0.39) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309426 0.91 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29567055 0.87 HTR1A (0.40) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309427 0.87 HTR1A (0.40) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29566521 0.85 HTR1A (0.38) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29566770 0.85 BRD4 (0.36) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL24309993 0.85 BRD4 (0.36) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL24310452 0.85 HTR1A (0.38) HTR1AHTR7DRD2HTR6THRB
SCHEMBL26811975 0.84 HTR1A (0.35) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309827 0.81 HTR1A (0.43) HTR1AHTR7DRD2HTR6THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback